Zeus Names Padraic 'Paddy' O'Brien As Chief Executive Officer In Strategic Growth Move

Zeus, a global frontrunner in the production of custom polymer components, has officially announced the appointment of Padraic "Paddy" O'Brien as its new Chief Executive Officer, starting from April 1, 2024. This strategic move comes at a crucial time as Zeus embarks on an ambitious growth trajectory under the new ownership of EQT. O'Brien, who is transitioning from his role as Worldwide President of BD Peripheral Intervention at Becton, Dickinson and Company (BD), brings a wealth of experience and a proven track record in leading teams to sustainable growth and fostering a culture of success.

O'Brien's career at BD, marked by leadership roles that spanned over a decade, showcases his ability to drive growth and innovation within the medical technology sector. His tenure at BD, especially after its acquisition of Bard in December 2017, has prepared him for the challenges and opportunities that lie ahead with Zeus. With a Bachelor of Science in Combined Sciences from Santa Clara University, O'Brien's academic background complements his extensive professional experience.

Ethan Waxman, Partner within EQT Private Equity's Advisory Team, emphasized the thorough search process that led to O'Brien's selection. Waxman highlighted O'Brien's deep domain knowledge and leadership capabilities as key factors that make him well-suited to guide Zeus through its next phase of expansion. The company is poised for significant investments in capacity enhancement, process improvements, and product innovation under O'Brien's leadership.

John Groetelaars, Executive Chairman at Zeus, expressed enthusiasm about O'Brien's appointment. He pointed out O'Brien's profound understanding of the interventional markets and his track record of driving growth as crucial assets for Zeus' future. Groetelaars is confident in O'Brien's ability to lead the company into a new era of development and success.

About Zeus

Headquartered in Orangeburg, South Carolina, Zeus stands as the premier manufacturer of polymer extrusion and catheter design. With over 55 years serving industries such as medical, aerospace, energy, automotive, and fiber optics, Zeus is committed to innovation and enhancing lives through its solutions. The company boasts a global workforce of over 2,400 employees across facilities in the United States and Ireland. For further details on Zeus and its offerings, visit their website.

The appointment of Padraic "Paddy" O'Brien as CEO marks a significant milestone for Zeus as it navigates through an exciting period of growth and innovation. With O'Brien at the helm, backed by his extensive experience and strategic vision, Zeus is well-positioned to continue its legacy of excellence and leadership in the polymer extrusion and catheter design industry.